Genomic and clinical epidemiology of SARS-CoV-2 in Lebanon: a prospective multicenter study 2020–2024
Fatima Dakroub, Celina F. Boutros, Diego Teixeira, Habib Alkalamouni, Nagham Hamzah, Nancy Hourani, Amani Haddara, Samar Dalle, Dima Khreis, Elsy Tawil, Silma Baasiri, Zeinab El Zein, Mayse Naser, Rawan Korman, Maher Sraj, Yara Salameh, Sarah Merhi, Kawthar Faour, Nadim Tfaily

TL;DR
This study tracks the spread and severity of COVID-19 in Lebanon from 2020 to 2024, finding that vaccination and pneumonia management are key to reducing mortality.
Contribution
The study provides new insights into the genomic and clinical evolution of SARS-CoV-2 in Lebanon, linking viral clades to local transmission and mortality risk factors.
Findings
Severe outcomes like pneumonia and mortality decreased over time in Lebanon.
Three vaccine doses significantly reduced mortality risk.
Genomic analysis showed multiple introductions of SARS-CoV-2 clades into Lebanon.
Abstract
Globally, the trajectory of COVID-19 has been shaped by viral evolution, widespread vaccination and immunity from prior infections. We assessed the epidemiological and clinical patterns of COVID-19 in Lebanon between 2020 and 2024, identified the predominant SARS-CoV-2 clades and evaluated risk factors for COVID-19 associated mortality. This multicenter prospective study enrolled 1302 patients hospitalized with COVID-19 in Lebanon between November 2020 and October 2024. Multivariate logistic regression was used to determine predictors of COVID-19 associated mortality. Whole genome sequencing (WGS) was utilized to investigate the genomic epidemiology of SARS-CoV-2 and infer viral interactions between Lebanon and other countries. Multiple sequence alignment and phylogenetic analysis were conducted using the augur pipeline. A progressive and significant reduction in severe outcomes,…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 6Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsSARS-CoV-2 and COVID-19 Research · COVID-19 Clinical Research Studies · Immune responses and vaccinations
